Log In
Saturday 26th May 2018

Medical journal accused by GSK

8th June 2007

The head of a UK-based pharmaceutical group has criticised a leading medical journal for “mixing science with politics� in publishing articles attacking its diabetes drug Avandia.

Jean-Pierre Garnier, chief executive of GlaxoSmithKline, criticised New England Journal of Medicine papers raising safety concerns with Avandia which he said were “smearing the drug.� As the GSK share price continued to fall, he was speaking as GSK mounted a fresh defence on the safety of Avandia during hearings in Washington triggered by the NEJM’s article last month suggesting an increased risk of heart attack associated with the drug.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

M3 - For secure managed hosting over N3 or internet
© Mayden Foundation 2018